Virtus Fund Advisers, LLC Blueprint Medicines Corp Transaction History
Virtus Fund Advisers, LLC
- $25 Million
- Q2 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 147 shares of BPMC stock, worth $13,437. This represents 0.06% of its overall portfolio holdings.
Number of Shares
147
Previous 163
9.82%
Holding current value
$13,437
Previous $15,000
-0.0%
% of portfolio
0.06%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$608 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$598 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$537 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$296 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$225 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.46B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...